Literature DB >> 17545153

Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling.

Min Chen1, Minying Cai, Charles J Aprahamian, Keith E Georgeson, Victor Hruby, Carroll M Harmon, Yingkui Yang.   

Abstract

Melanocortin 4 receptor (MC4R) plays an important role in the regulation of food intake and body weight. To determine the molecular basis of human MC4R (hMC4R) responsible for alpha-melanocortin-stimulating hormone (alpha-MSH) binding, in this study, we utilized both receptor domain exchange and site-directed mutagenesis studies to investigate the molecular determinants of hMC4R responsible for alpha-MSH binding and signaling. alpha-MSH is a potent agonist at hMC4R but not at hMC2R. Cassette substitutions of the second, third, fourth, fifth, and sixth transmembrane regions (TM) of the hMC4R with the homologous regions of hMC2R were performed and alpha-MSH binding and signaling were examined. Our results indicate that each chimeric receptor was expressed at the cell surface and the expression levels remain similar to that of the wild-type receptor. The cassette substitutions of the second, fourth, fifth, and sixth TMs of the hMC4R with homologous regions of the hMC2R did not significantly alter alpha-MSH binding affinity and potency except substitution of the TM3 of the hMC4R, suggesting that the conserved residues in TMs of the hMC4R are crucial for alpha-MSH binding and signaling. Further mutagenesis studies indicate that conserved residues Glu(100) in TM2, Asp(122), Asp(126) in TM3 and Trp(258), Phe(261), His(264) in TM6 are involved in alpha-MSH binding and signaling. In conclusion, our results suggest that the conserved residues in the TM2, TM3, and TM6 of the hMC4R are responsible for alpha-MSH binding and signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545153      PMCID: PMC2704061          DOI: 10.1074/jbc.M702285200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

Authors:  Kurt Kristiansen
Journal:  Pharmacol Ther       Date:  2004-07       Impact factor: 12.310

2.  Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1.

Authors:  L S Mizoue; J F Bazan; E C Johnson; T M Handel
Journal:  Biochemistry       Date:  1999-02-02       Impact factor: 3.162

3.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

4.  Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency.

Authors:  I S Farooqi; G S Yeo; J M Keogh; S Aminian; S A Jebb; G Butler; T Cheetham; S O'Rahilly
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation.

Authors:  Kristine Hogan; Stephan Peluso; Sandy Gould; Ian Parsons; Dominic Ryan; Lijun Wu; Irache Visiers
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

6.  Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.

Authors:  Y k Yang; C Dickinson; C Haskell-Luevano; I Gantz
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

7.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.

Authors:  W Fan; B A Boston; R A Kesterson; V J Hruby; R D Cone
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

8.  Melanocortin-4 receptor gene variant I103 is negatively associated with obesity.

Authors:  Frank Geller; Kathrin Reichwald; Astrid Dempfle; Thomas Illig; Caren Vollmert; Stephan Herpertz; Winfried Siffert; Matthias Platzer; Claudia Hess; Thomas Gudermann; Heike Biebermann; H-Erich Wichmann; Helmut Schäfer; Anke Hinney; Johannes Hebebrand
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

9.  Contribution of melanocortin receptor exoloops to Agouti-related protein binding.

Authors:  Y K Yang; C J Dickinson; Q Zeng; J Y Li; D A Thompson; I Gantz
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

10.  The probable arrangement of the helices in G protein-coupled receptors.

Authors:  J M Baldwin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  27 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

2.  Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists.

Authors:  Minying Cai; Udaya Kiran Marelli; Blake Mertz; Johannes G Beck; Florian Opperer; Florian Rechenmacher; Horst Kessler; Victor J Hruby
Journal:  Biochemistry       Date:  2017-08-01       Impact factor: 3.162

Review 3.  The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.

Authors:  Minying Cai; Victor J Hruby
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

Review 4.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

5.  Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.

Authors:  Paolo Grieco; Diego Brancaccio; Ettore Novellino; Victor J Hruby; Alfonso Carotenuto
Journal:  Eur J Med Chem       Date:  2011-05-23       Impact factor: 6.514

Review 6.  Structure, function and regulation of the melanocortin receptors.

Authors:  Yingkui Yang
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

7.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

Review 8.  Update on melanocortin interventions for cachexia: progress toward clinical application.

Authors:  Mark Daniel DeBoer
Journal:  Nutrition       Date:  2009-12-08       Impact factor: 4.008

Review 9.  Design of cyclized selective melanotropins.

Authors:  Minying Cai; Victor J Hruby
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

10.  Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.